TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs566529
log Bayes Factor = 0.0353148
Chromosome 2   position 234,756,811  (GRCh37) Explore rs566529 on Ensembl!
Variant rs566529 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
N28.1 Cyst of kidney, acquired
0.137 0.863 0.000
N28 Other disorders of kidney and ureter, not elsewhere classified
0.124 0.876 0.000
N28.8 Other specified disorders of kidney and ureter
0.123 0.877 0.000
N28.0 Ischaemia and infarction of kidney
0.084 0.916 0.000
N25-N29 Other disorders of kidney and ureter
0.078 0.922 0.000
N26 Unspecified contracted kidney
0.067 0.933 0.000
N27 Small kidney of unknown cause
0.064 0.935 0.000
N29 Other disorders of kidney and ureter in diseases classified elsewhere
0.056 0.944 0.000
N27.0 Small kidney, unilateral
0.055 0.945 0.000
N28.9 Disorder of kidney and ureter, unspecified
0.054 0.946 0.000
N25 Disorders resulting from impaired renal tubular function
0.048 0.952 0.000
N27.9 Small kidney, unspecified
0.046 0.953 0.000
N27.1 Small kidney, bilateral
0.046 0.953 0.000
N29.8 Other disorders of kidney and ureter in other diseases classified elsewhere
0.040 0.960 0.000
N29.1 Other disorders of kidney and ureter in infectious and parasitic diseases classified elsewhere
0.040 0.960 0.000
N29.0 Late syphilis of kidney
0.040 0.960 0.000
G91.9 Hydrocephalus, unspecified
0.038 0.962 0.000
N25.9 Disorder resulting from impaired renal tubular function, unspecified
0.034 0.965 0.000
N25.1 Nephrogenic diabetes insipidus
0.034 0.965 0.000
N25.0 Renal osteodystrophy
0.034 0.965 0.000
G91 Hydrocephalus
0.033 0.967 0.000
G90-G99 Other disorders of the nervous system
0.029 0.971 0.000
N25.8 Other disorders resulting from impaired renal tubular function
0.026 0.974 0.000
G99 Other disorders of nervous system in diseases classified elsewhere
0.026 0.974 0.000
H00.1 Chalazion
0.000 0.974 0.026
G97 Postprocedural disorders of nervous system, not elsewhere classified
0.025 0.975 0.000
G91.8 Other hydrocephalus
0.025 0.975 0.000
G91.0 Communicating hydrocephalus
0.025 0.975 0.000
G91.2 Normal-pressure hydrocephalus
0.025 0.975 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.024 0.976 0.000
G91.3 Posttraumatic hydrocephalus, unspecified
0.024 0.976 0.000
G99.2 Myelopathy in diseases classified elsewhere
0.023 0.977 0.000
G95 Other diseases of spinal cord
0.022 0.978 0.000
G97.8 Other postprocedural disorders of nervous system
0.022 0.978 0.000
G99.0 Autonomic neuropathy in endocrine and metabolic diseases
0.022 0.978 0.000
G98 Other disorders of nervous system, not elsewhere classified
0.021 0.979 0.000
G93 Other disorders of brain
0.021 0.979 0.000
G94.2 Hydrocephalus in other diseases classified elsewhere
0.021 0.979 0.000
G92 Toxic encephalopathy
0.021 0.979 0.000
G93.4 Encephalopathy, unspecified
0.020 0.980 0.000
C83.3 Large cell (diffuse)
0.000 0.980 0.020
G97.1 Other reaction to spinal and lumbar puncture
0.020 0.980 0.000
G91.1 Obstructive hydrocephalus
0.020 0.980 0.000
G97.0 Cerebrospinal fluid leak from spinal puncture
0.019 0.981 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.981 0.019
G99.8 Other specified disorders of nervous system in diseases classified elsewhere
0.019 0.981 0.000
G99.1 Other disorders of autonomic nervous system in other diseases classified elsewhere
0.019 0.981 0.000
G95.1 Vascular myelopathies
0.019 0.981 0.000
G97.9 Postprocedural disorder of nervous system, unspecified
0.018 0.981 0.000
G97.2 Intracranial hypotension following ventricular shunting
0.018 0.981 0.000
G90 Disorders of autonomic nervous system
0.018 0.982 0.000
G96 Other disorders of central nervous system
0.018 0.982 0.000
G95.0 Syringomyelia and syringobulbia
0.018 0.982 0.000
G95.9 Disease of spinal cord, unspecified
0.018 0.982 0.000
G94.8 Other specified disorders of brain in diseases classified elsewhere
0.017 0.982 0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere
0.017 0.982 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.983 0.017
G93.6 Cerebral oedema
0.017 0.983 0.000
C83.0 Small cell (diffuse)
0.000 0.983 0.017
G93.1 Anoxic brain damage, not elsewhere classified
0.017 0.983 0.000
G93.2 Benign intracranial hypertension
0.017 0.983 0.000
G94.1 Hydrocephalus in neoplastic disease
0.017 0.983 0.000
G95.8 Other specified diseases of spinal cord
0.016 0.984 0.000
G93.5 Compression of brain
0.016 0.984 0.000
G93.7 Reye's syndrome
0.015 0.984 0.000
C81.9 Hodgkin's disease, unspecified
0.000 0.984 0.016
C81 Hodgkin's disease
0.000 0.984 0.016
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.985 0.015
G90.9 Disorder of autonomic nervous system, unspecified
0.014 0.985 0.000
G93.0 Cerebral cysts
0.014 0.985 0.000
C83.7 Burkitt's tumour
0.000 0.986 0.014
C83.6 Undifferentiated (diffuse)
0.000 0.986 0.014
C83.5 Lymphoblastic (diffuse)
0.000 0.986 0.014
C83.4 Immunoblastic (diffuse)
0.000 0.986 0.014
C83.2 Mixed small and large cell (diffuse)
0.000 0.986 0.014
C81.1 Nodular sclerosis
0.000 0.986 0.014
C83.1 Small cleaved cell (diffuse)
0.000 0.986 0.014
G93.9 Disorder of brain, unspecified
0.013 0.986 0.000
G90.8 Other disorders of autonomic nervous system
0.013 0.987 0.000
G90.4 Autonomic dysreflexia
0.013 0.987 0.000
G90.1 Familial dysautonomia [Riley-Day]
0.013 0.987 0.000
G96.9 Disorder of central nervous system, unspecified
0.013 0.987 0.000
G96.8 Other specified disorders of central nervous system
0.013 0.987 0.000
G96.1 Disorders of meninges, not elsewhere classified
0.013 0.987 0.000
H00 Hordeolum and chalazion
0.000 0.987 0.013
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.987 0.013
G90.2 Horner's syndrome
0.012 0.988 0.000
G90.0 Idiopathic peripheral autonomic neuropathy
0.012 0.988 0.000
T78.3 Angioneurotic oedema
0.000 0.988 0.012
G90.3 Multisystem degeneration
0.012 0.988 0.000
C88 Malignant immunoproliferative diseases
0.000 0.988 0.012
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.988 0.011
C81.7 Other Hodgkin's disease
0.000 0.989 0.011
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.989 0.011
C81.3 Lymphocytic depletion
0.000 0.989 0.011
C81.2 Mixed cellularity
0.000 0.989 0.011
C81.0 Lymphocytic predominance
0.000 0.989 0.011
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.989 0.011
C85.7 Other specified types of non-Hodgkin's lymphoma
0.000 0.989 0.011
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.989 0.011
C94 Other leukaemias of specified cell type
0.000 0.989 0.011
C93 Monocytic leukaemia
0.000 0.989 0.011
C86 Other specified types of T/NK-cell lymphoma
0.000 0.989 0.011
C91 Lymphoid leukaemia
0.000 0.989 0.011
G96.0 Cerebrospinal fluid leak
0.010 0.989 0.000
H00.0 Hordeolum and other deep inflammation of eyelid
0.000 0.989 0.010
R19.8 Other specified symptoms and signs involving the digestive system and abdomen
0.010 0.990 0.000
G95.2 Cord compression, unspecified
0.010 0.990 0.000
C85.1 B-cell lymphoma, unspecified
0.000 0.990 0.010
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.990 0.010
T78 Adverse effects, not elsewhere classified
0.000 0.990 0.010
C67.4 Posterior wall of bladder
0.010 0.990 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.990 0.009
C90 Multiple myeloma and malignant plasma cell neoplasms
0.000 0.991 0.009
G93.8 Other specified disorders of brain
0.009 0.991 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.991 0.009
C85.0 Lymphosarcoma
0.000 0.991 0.009
C84.4 Peripheral T-cell lymphoma
0.000 0.991 0.009
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.000 0.991 0.009
C95 Leukaemia of unspecified cell type
0.000 0.991 0.009
T78.4 Allergy, unspecified
0.000 0.991 0.009
C91.4 Hairy-cell leukaemia
0.000 0.991 0.009
C91.0 Acute lymphoblastic leukaemia
0.000 0.991 0.009
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.991 0.008
C88.7 Other malignant immunoproliferative diseases
0.000 0.991 0.008
C88.3 Immunoproliferative small intestinal disease
0.000 0.991 0.008
C88.2 Gamma heavy chain disease
0.000 0.991 0.008
C88.1 Alpha heavy chain disease
0.000 0.991 0.008
C84.5 Other and unspecified T-cell lymphomas
0.000 0.991 0.008
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.991 0.008
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.991 0.008
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.991 0.008
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.991 0.008
C84.3 Lymphoepithelioid lymphoma
0.000 0.991 0.008
C84.2 T-zone lymphoma
0.000 0.991 0.008
C84.1 Sezary's diease
0.000 0.991 0.008
C84.0 Mycosis fungoides
0.000 0.991 0.008
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.992 0.008
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.992 0.008
N50.1 Vascular disorders of male genital organs
0.008 0.992 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.992 0.008
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.992 0.008
C86.4 Blastic NK-cell lymphoma
0.000 0.992 0.008
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.992 0.008
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.992 0.008
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.992 0.008
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.992 0.008
C93.9 Monocytic leukaemia, unspecified
0.000 0.992 0.008
C93.7 Other monocytic leukaemia
0.000 0.992 0.008
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.992 0.008
C93.2 Subacute monocytic leukaemia
0.000 0.992 0.008
C93.1 Chronic monocytic leukaemia
0.000 0.992 0.008
C93.0 Acute monocytic leukaemia
0.000 0.992 0.008
C94.7 Other specified leukaemias
0.000 0.992 0.008
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.992 0.008
C94.5 Acute myelofibrosis
0.000 0.992 0.008
C94.4 Acute panmyelosis
0.000 0.992 0.008
C94.3 Mast cell leukaemia
0.000 0.992 0.008
C94.2 Acute megakaryoblastic leukaemia
0.000 0.992 0.008
C94.1 Chronic erythraemia
0.000 0.992 0.008
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.992 0.008
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.992 0.008
C96.8 Histiocytic sarcoma
0.000 0.992 0.008
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.992 0.008
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.992 0.008
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.992 0.008
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.992 0.008
C96.3 True histiocytic lymphoma
0.000 0.992 0.008
C96.2 Malignant mast cell tumour
0.000 0.992 0.008
C96.1 Malignant histiocytosis
0.000 0.992 0.008
C96.0 Letterer-Siwe disease
0.000 0.992 0.008
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.992 0.008
C91.7 Other lymphoid leukaemia
0.000 0.992 0.008
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.992 0.008
C91.5 Adult T-cell leukaemia
0.000 0.992 0.008
C91.3 Prolymphocytic leukaemia
0.000 0.992 0.008
C91.2 Subacute lymphocytic leukaemia
0.000 0.992 0.008
T78.2 Anaphylactic shock, unspecified
0.000 0.992 0.008
T78.0 Anaphylactic shock due to adverse food reaction
0.000 0.992 0.008
C67 Malignant neoplasm of bladder
0.008 0.992 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.000 0.992 0.007
C82.6 Cutaneous follicle centre lymphoma
0.000 0.993 0.007
C82.5 Diffuse follicle centre lymphoma
0.000 0.993 0.007
C82.4 Follicular lymphoma grade IIIb
0.000 0.993 0.007
C82.2 Large cell, follicular
0.000 0.993 0.007
G93.3 Postviral fatigue syndrome
0.007 0.993 0.000
T78.9 Adverse effect, unspecified
0.000 0.993 0.007
T78.8 Other adverse effects, not elsewhere classified
0.000 0.993 0.007
C90.1 Plasma cell leukaemia
0.000 0.993 0.007
C90.0 Multiple myeloma
0.000 0.993 0.007
C67.1 Dome of bladder
0.007 0.993 0.000
I31.3 Pericardial effusion (noninflammatory)
0.000 0.993 0.007
C91.1 Chronic lymphocytic leukaemia
0.000 0.993 0.007
C82.0 Small cleaved cell, follicular
0.000 0.993 0.007
T78.1 Other adverse food reactions, not elsewhere classified
0.000 0.993 0.007
C95.7 Other leukaemia of unspecified cell type
0.000 0.993 0.006
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.993 0.006
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.993 0.006
C95.0 Acute leukaemia of unspecified cell type
0.000 0.993 0.006
C91.9 Lymphoid leukaemia, unspecified
0.000 0.993 0.007
C92 Myeloid leukaemia
0.000 0.993 0.007
C90.3 Solitary plasmacytoma
0.000 0.993 0.007
C67.0 Trigone of bladder
0.007 0.993 0.000
C82.3 Follicular lymphoma grade IIIa
0.000 0.993 0.006
C67.6 Ureteric orifice
0.006 0.994 0.000
C90.2 Plasmacytoma, extramedullary
0.000 0.994 0.006
C67.2 Lateral wall of bladder
0.006 0.994 0.000
C67.3 Anterior wall of bladder
0.006 0.994 0.000
C67.7 Urachus
0.006 0.994 0.000
E80.4 Gilbert's syndrome
0.006 0.994 0.000
C67.5 Bladder neck
0.005 0.995 0.000
I31.9 Disease of pericardium, unspecified
0.000 0.995 0.005
C92.9 Myeloid leukaemia, unspecified
0.000 0.995 0.005
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.995 0.005
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.995 0.005
C92.5 Acute myelomonocytic leukaemia
0.000 0.995 0.005
C92.4 Acute promyelocytic leukaemia
0.000 0.995 0.005
C92.3 Myeloid sarcoma
0.000 0.995 0.005
C92.2 Subacute myeloid leukaemia
0.000 0.995 0.005
C95.9 Leukaemia, unspecified
0.001 0.995 0.005
I31 Other diseases of pericardium
0.000 0.995 0.005
N94.6 Dysmenorrhoea, unspecified
0.000 0.995 0.005
C67.8 Overlapping lesion of bladder
0.005 0.995 0.000
C67.9 Bladder, unspecified
0.005 0.995 0.000
C92.1 Chronic myeloid leukaemia
0.000 0.995 0.004
E83.3 Disorders of phosphorus metabolism
0.005 0.995 0.000
I61.9 Intracerebral haemorrhage, unspecified
0.004 0.996 0.000
C92.7 Other myeloid leukaemia
0.000 0.996 0.004
E87.5 Hyperkalaemia
0.004 0.996 0.000
N73.6 Female pelvic peritoneal adhesions
0.000 0.996 0.004
E80 Disorders of porphyrin and bilirubin metabolism
0.004 0.996 0.000
I61.8 Other intracerebral haemorrhage
0.004 0.996 0.000
Z93.6 Other artificial openings of urinary tract status
0.004 0.996 0.000
S80.9 Superficial injury of lower leg, unspecified
0.004 0.996 0.000
I31.8 Other specified diseases of pericardium
0.000 0.996 0.004
I31.2 Haemopericardium, not elsewhere classified
0.000 0.996 0.004
I31.1 Chronic constrictive pericarditis
0.000 0.996 0.004
I31.0 Chronic adhesive pericarditis
0.000 0.996 0.004
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.004 0.996 0.000
I61 Intracerebral haemorrhage
0.004 0.996 0.000
I61.5 Intracerebral haemorrhage, intraventricular
0.004 0.996 0.000
E80.6 Other disorders of bilirubin metabolism
0.004 0.996 0.000
S01.2 Open wound of nose
0.003 0.996 0.000
C92.0 Acute myeloid leukaemia
0.000 0.997 0.003
E80.7 Disorder of bilirubin metabolism, unspecified
0.003 0.997 0.000
E80.5 Crigler-Najjar syndrome
0.003 0.997 0.000
E80.3 Defects of catalase and peroxydase
0.003 0.997 0.000
E80.2 Other porphyria
0.003 0.997 0.000
E80.1 Porphyria cutanea tarda
0.003 0.997 0.000
E80.0 Hereditary erythropoietic porphyria
0.003 0.997 0.000
D17.9 Benign lipomatous neoplasm, unspecified
0.000 0.997 0.003
N71.9 Inflammatory disease of uterus, unspecified
0.000 0.997 0.003
N73.9 Female pelvic inflammatory disease, unspecified
0.000 0.997 0.003
D68.8 Other specified coagulation defects
0.003 0.997 0.000
N73 Other female pelvic inflammatory diseases
0.000 0.997 0.003
N99.3 Prolapse of vaginal vault after hysterectomy
0.000 0.997 0.003
E83 Disorders of mineral metabolism
0.003 0.997 0.000
C34.1 Upper lobe, bronchus or lung
0.000 0.997 0.003
I61.6 Intracerebral haemorrhage, multiple localised
0.003 0.997 0.000
Z93.4 Other artificial openings of gastro-intestinal tract status
0.003 0.997 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.997 0.003
C34.9 Bronchus or lung, unspecified
0.000 0.997 0.003
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.003 0.997 0.000
E83.1 Disorders of iron metabolism
0.003 0.997 0.000
E85.9 Amyloidosis, unspecified
0.003 0.997 0.000
E85 Amyloidosis
0.003 0.997 0.000
E87 Other disorders of fluid, electrolyte and acid-base balance
0.003 0.997 0.000
I61.3 Intracerebral haemorrhage in brain stem
0.003 0.997 0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.003 0.997 0.000
Z93 Artificial opening status
0.003 0.997 0.000
D09.0 Bladder
0.003 0.997 0.000
Z93.2 Ileostomy status
0.003 0.997 0.000
E70-E90 Metabolic disorders
0.003 0.997 0.000
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified
0.003 0.997 0.000
T66-T78 Other and unspecified effects of external causes
0.000 0.997 0.003
S22.30 Fracture of rib (closed)
0.000 0.997 0.003
C34 Malignant neoplasm of bronchus and lung
0.000 0.997 0.003
E87.0 Hyperosmolality and hypernatraemia
0.003 0.997 0.000
E85.4 Organ-limited amyloidosis
0.002 0.997 0.000
H49.2 Sixth [abducent] nerve palsy
0.003 0.997 0.000
E87.7 Fluid overload
0.003 0.997 0.000
I61.4 Intracerebral haemorrhage in cerebellum
0.002 0.997 0.000
N73.8 Other specified female pelvic inflammatory diseases
0.000 0.997 0.002
N73.4 Female chronic pelvic peritonitis
0.000 0.997 0.002
N73.3 Female acute pelvic peritonitis
0.000 0.997 0.002
N73.2 Unspecified parametritis and pelvic cellulitis
0.000 0.997 0.002
N73.1 Chronic parametritis and pelvic cellulitis
0.000 0.997 0.002
D68.9 Coagulation defect, unspecified
0.000 0.997 0.002
D68.0 Von Willebrand's disease
0.002 0.997 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.002 0.997 0.000
E83.8 Other disorders of mineral metabolism
0.002 0.997 0.000
E83.2 Disorders of zinc metabolism
0.002 0.997 0.000
E83.0 Disorders of copper metabolism
0.002 0.997 0.000
D68.6 Other Thrombophilia
0.002 0.997 0.000
N80.2 Endometriosis of Fallopian tube
0.002 0.997 0.000
M47.87 Other spondylosis (Lumbosacral region)
0.002 0.998 0.000
C34.3 Lower lobe, bronchus or lung
0.000 0.998 0.002
E83.4 Disorders of magnesium metabolism
0.002 0.998 0.000
N73.5 Female pelvic peritonitis, unspecified
0.000 0.998 0.002
S62.60 Fracture of other finger (closed)
0.000 0.998 0.002
R41.3 Other amnesia
0.000 0.998 0.002
Z93.8 Other artificial opening status
0.002 0.998 0.000
Z93.3 Colostomy status
0.002 0.998 0.000
E79 Disorders of purine and pyrimidine metabolism
0.002 0.998 0.000
E88 Other metabolic disorders
0.002 0.998 0.000
R94.4 Abnormal results of kidney function studies
0.002 0.998 0.000
E85.8 Other amyloidosis
0.002 0.998 0.000
E85.2 Heredofamilial amyloidosis, unspecified
0.002 0.998 0.000
E85.1 Neuropathic heredofamilial amyloidosis
0.002 0.998 0.000
E85.0 Nonneuropathic heredofamilial amyloidosis
0.002 0.998 0.000
N73.0 Acute parametritis and pelvic cellulitis
0.000 0.998 0.002
C64-C68 Malignant neoplasms of urinary tract
0.002 0.998 0.000
D52.9 Folate deficiency anaemia, unspecified
0.000 0.998 0.002
E85.3 Secondary systemic amyloidosis
0.002 0.998 0.000
E87.4 Mixed disorder of acid-base balance
0.002 0.998 0.000
C34.0 Main bronchus
0.000 0.998 0.002
E87.3 Alkalosis
0.002 0.998 0.000
M43.16 Spondylolisthesis (Lumbar region)
0.000 0.998 0.002
M75.5 Bursitis of shoulder
0.002 0.998 0.000
C65 Malignant neoplasm of renal pelvis
0.002 0.998 0.000
D68 Other coagulation defects
0.002 0.998 0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.002 0.998 0.000
T66 Unspecified effects of radiation
0.000 0.998 0.002
N71 Inflammatory disease of uterus, except cervix
0.000 0.998 0.002
Z93.5 Cystostomy status
0.002 0.998 0.000
E84 Cystic fibrosis
0.002 0.998 0.000
E77 Disorders of glycoprotein metabolism
0.002 0.998 0.000
E76 Disorders of glycosaminoglycan metabolism
0.002 0.998 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.002 0.998 0.000
E72 Other disorders of amino-acid metabolism
0.002 0.998 0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.002 0.998 0.000
E70 Disorders of aromatic amino-acid metabolism
0.002 0.998 0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.002 0.998 0.000
T74 Maltreatment syndromes
0.000 0.998 0.002
T73 Effects of other deprivation
0.000 0.998 0.002
T69 Other effects of reduced temperature
0.000 0.998 0.002
T67 Effects of heat and light
0.000 0.998 0.002
E74 Other disorders of carbohydrate metabolism
0.002 0.998 0.000
H58.8 Visual disturbances in diseases classified elsewhere
0.002 0.998 0.000
O42.9 Premature rupture of membranes, unspecified
0.000 0.998 0.002
R00.0 Tachycardia, unspecified
0.002 0.998 0.000
T70 Effects of air pressure and water pressure
0.000 0.998 0.002
C34.8 Overlapping lesion of bronchus and lung
0.000 0.998 0.002
N92.0 Excessive and frequent menstruation with regular cycle
0.000 0.998 0.002
Z97.4 Presence of external hearing-aid
0.002 0.998 0.000
E88.2 Lipomatosis, not elsewhere classified
0.002 0.998 0.000
M95.0 Acquired deformity of nose
0.000 0.998 0.002
Z93.9 Artificial opening status, unspecified
0.002 0.998 0.000
N50 Other disorders of male genital organs
0.002 0.998 0.000
T75 Effects of other external causes
0.000 0.998 0.002
G61.0 Guillain-Barre syndrome
0.000 0.998 0.002
H21.9 Disorder of iris and ciliary body, unspecified
0.002 0.998 0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.002 0.998 0.000
E79.8 Other disorders of purine and pyrimidine metabolism
0.002 0.998 0.000
E79.1 Lesch-Nyhan syndrome
0.002 0.998 0.000
G63.2 Diabetic polyneuropathy
0.000 0.998 0.002
H54.9 Unspecified visual impairment (binocular)
0.002 0.998 0.000
T71 Asphyxiation
0.000 0.998 0.002
E88.9 Metabolic disorder, unspecified
0.002 0.998 0.000
E88.8 Other specified metabolic disorders
0.002 0.998 0.000
E88.3 Tumour lysis syndrome
0.002 0.998 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.002 0.998 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.002 0.998 0.000
H21.0 Hyphaema
0.002 0.998 0.000
N71.1 Chronic inflammatory disease of uterus
0.000 0.998 0.002
H21 Other disorders of iris and ciliary body
0.002 0.998 0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants
0.002 0.998 0.000
C68 Malignant neoplasm of other and unspecified urinary organs
0.002 0.998 0.000
E73 Lactose intolerance
0.002 0.998 0.000
D68.1 Hereditary factor XI deficiency
0.002 0.998 0.000
D68.4 Acquired coagulation factor deficiency
0.002 0.998 0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified
0.000 0.998 0.002
Z87.2 Personal history of diseases of the skin and subcutaneous tissue
0.002 0.998 0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.002 0.998 0.000
E70.8 Other disorders of aromatic amino-acid metabolism
0.002 0.998 0.000
E70.3 Albinism
0.002 0.998 0.000
E70.2 Disorders of tyrosine metabolism
0.002 0.998 0.000
E70.1 Other hyperphenylalaninaemias
0.002 0.998 0.000
E70.0 Classical phenylketonuria
0.002 0.998 0.000
E71.3 Disorders of fatty-acid metabolism
0.002 0.998 0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.002 0.998 0.000
E71.1 Other disorders of branched-chain amino-acid metabolism
0.002 0.998 0.000
E71.0 Maple-syrup-urine disease
0.002 0.998 0.000
E72.9 Disorder of amino-acid metabolism, unspecified
0.002 0.998 0.000
E72.8 Other specified disorders of amino-acid metabolism
0.002 0.998 0.000
E72.5 Disorders of glycine metabolism
0.002 0.998 0.000
E72.4 Disorders of ornithine metabolism
0.002 0.998 0.000
E72.3 Disorders of lysine and hydroxylysine metabolism
0.002 0.998 0.000
E72.2 Disorders of urea cycle metabolism
0.002 0.998 0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.002 0.998 0.000
E72.0 Disorders of amino-acid transport
0.002 0.998 0.000
E75.6 Lipid storage disorder, unspecified
0.002 0.998 0.000
E75.5 Other lipid storage disorders
0.002 0.998 0.000
E75.4 Neuronal ceroid lipofuscinosis
0.002 0.998 0.000
E75.3 Sphingolipidosis, unspecified
0.002 0.998 0.000
E75.2 Other sphingolipidosis
0.002 0.998 0.000
E75.1 Other gangliosidosis
0.002 0.998 0.000
E75.0 GM2 gangliosidosis
0.002 0.998 0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.002 0.998 0.000
E76.8 Other disorders of glucosaminoglycan metabolism
0.002 0.998 0.000
E76.3 Mucopolysaccharidosis, unspecified
0.002 0.998 0.000
E76.2 Other mucopolysaccharidoses
0.002 0.998 0.000
E76.1 Mucopolysaccharidosis, type II
0.002 0.998 0.000
E76.0 Mucopolysaccharidosis, type I
0.002 0.998 0.000
E77.9 Disorder of glycoprotein metabolism, unspecified
0.002 0.998 0.000
E77.8 Other disorders of glycoprotein metabolism
0.002 0.998 0.000
E77.1 Defects in glycoprotein degradation
0.002 0.998 0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.002 0.998 0.000
E84.9 Cystic fibrosis, unspecified
0.002 0.998 0.000
E84.8 Cystic fibrosis with other manifestations
0.002 0.998 0.000
E84.1 Cystic fibrosis with intestinal manifestations
0.002 0.998 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.002 0.998 0.000
K12.1 Other forms of stomatitis
0.000 0.998 0.002
T67.9 Effects of heat and light, unspecified
0.000 0.998 0.002
T67.8 Other effects of heat and light
0.000 0.998 0.002
T67.7 Heat oedema
0.000 0.998 0.002
T67.6 Heat fatigue, transient
0.000 0.998 0.002
T67.5 Heat exhaustion, unspecified
0.000 0.998 0.002
T67.4 Heat exhaustion due to salt depletion
0.000 0.998 0.002
T67.3 Heat exhaustion, anhydrotic
0.000 0.998 0.002
T67.2 Heat cramp
0.000 0.998 0.002
T67.1 Heat syncope
0.000 0.998 0.002
T67.0 Heatstroke and sunstroke
0.000 0.998 0.002
T69.9 Effect of reduced temperature, unspecified
0.000 0.998 0.002
T69.8 Other specified effects of reduced temperature
0.000 0.998 0.002
T69.1 Chilblains
0.000 0.998 0.002
T69.0 Immersion hand and foot
0.000 0.998 0.002
T73.9 Effect of deprivation, unspecified
0.000 0.998 0.002
T73.8 Other effects of deprivation
0.000 0.998 0.002
T73.3 Exhaustion due to excessive exertion
0.000 0.998 0.002
T73.2 Exhaustion due to exposure
0.000 0.998 0.002
T73.1 Effects of thirst
0.000 0.998 0.002
T73.0 Effects of hunger
0.000 0.998 0.002
T74.9 Maltreatment syndrome, unspecified
0.000 0.998 0.002
T74.8 Other maltreatment syndromes
0.000 0.998 0.002
T74.3 Psychological abuse
0.000 0.998 0.002
T74.2 Sexual abuse
0.000 0.998 0.002
T74.1 Physical abuse
0.000 0.998 0.002
T74.0 Neglect or abandonment
0.000 0.998 0.002
E74.9 Disorder of carbohydrate metabolism, unspecified
0.002 0.998 0.000
E74.8 Other specified disorders of carbohydrate metabolism
0.002 0.998 0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.002 0.998 0.000
E74.2 Disorders of galactose metabolism
0.002 0.998 0.000
E74.1 Disorders of fructose metabolism
0.002 0.998 0.000
E74.0 Glycogen storage disease
0.002 0.998 0.000
H21.1 Other vascular disorders of iris and ciliary body
0.002 0.998 0.000
T70.9 Effect of air pressure and water pressure, unspecified
0.000 0.998 0.002
T70.8 Other effects of air pressure and water pressure
0.000 0.998 0.002
T70.4 Effects of high-pressure fluids
0.000 0.998 0.002
T70.2 Other and unspecified effects of high altitude
0.000 0.998 0.002
T70.1 Sinus barotrauma
0.000 0.998 0.002
T70.0 Otitic barotrauma
0.000 0.998 0.002
G61 Inflammatory polyneuropathy
0.000 0.998 0.002
G61.8 Other inflammatory polyneuropathies
0.000 0.998 0.002
E74.3 Other disorders of intestinal carbohydrate absorption
0.002 0.998 0.000
K07.1 Anomalies of jaw-cranial base relationship
0.002 0.998 0.000
T70.3 Caisson disease [decompression sickness]
0.000 0.998 0.002
M19.98 Arthrosis, unspecified (Other)
0.000 0.998 0.002
D68.5 Primary Thrombophilia
0.002 0.998 0.000
H21.5 Other adhesions and disruptions of iris and ciliary body
0.002 0.998 0.000
N71.0 Acute inflammatory disease of uterus
0.000 0.998 0.002
T68 Hypothermia
0.000 0.998 0.002
K81.1 Chronic cholecystitis
0.002 0.998 0.000
N50.9 Disorder of male genital organs, unspecified
0.002 0.998 0.000
Z97.1 Presence of artificial limb (complete)(partial)
0.002 0.998 0.000
K12.0 Recurrent oral aphthae
0.000 0.998 0.002
T75.8 Other specified effects of external causes
0.000 0.998 0.001
T75.3 Motion sickness
0.000 0.998 0.001
T75.2 Effects of vibration
0.000 0.998 0.001
T75.1 Drowning and nonfatal submersion
0.000 0.998 0.001
T75.0 Effects of lightning
0.000 0.998 0.001
M19.94 Arthrosis, unspecified (Hand)
0.000 0.998 0.002
K81.9 Cholecystitis, unspecified
0.002 0.998 0.000
G63 Polyneuropathy in diseases classified elsewhere
0.000 0.998 0.002
Z93.0 Tracheostomy status
0.002 0.998 0.000
Z96.7 Presence of other bone and tendon implants
0.002 0.998 0.000
C66 Malignant neoplasm of ureter
0.002 0.998 0.000
H21.4 Pupillary membranes
0.002 0.998 0.000
H21.3 Cyst of iris, ciliary body and anterior chamber
0.002 0.998 0.000
H21.2 Degeneration of iris and ciliary body
0.002 0.998 0.000
C68.9 Urinary organ, unspecified
0.001 0.998 0.000
C68.8 Overlapping lesion of urinary organs
0.001 0.998 0.000
C68.1 Paraurethral glands
0.001 0.998 0.000
C68.0 Urethra
0.001 0.998 0.000
N50.0 Atrophy of testis
0.002 0.998 0.000
E73.8 Other lactose intolerance
0.001 0.998 0.000
E73.1 Secondary lactase deficiency
0.001 0.998 0.000
E73.0 Congenital lactase deficiency
0.001 0.998 0.000
E87.1 Hypo-osmolality and hyponatraemia
0.002 0.998 0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.002 0.998 0.000
K07.6 Temporomandibular joint disorders
0.002 0.998 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.002 0.998 0.000
Z97.0 Presence of artificial eye
0.002 0.998 0.000
C34.2 Middle lobe, bronchus or lung
0.000 0.998 0.001
I24.8 Other forms of acute ischaemic heart disease
0.000 0.998 0.002
H21.8 Other specified disorders of iris and ciliary body
0.002 0.998 0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs
0.000 0.998 0.002
T75.4 Effects of electric current
0.000 0.998 0.001
G61.1 Serum neuropathy
0.000 0.998 0.001
S80 Superficial injury of lower leg
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.